Virginia STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Virginia STEM News.

Press releases published on October 7, 2026

Oct. 7, 2026

Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026

Indeterminate GlobeNewswire

Oct. 7, 2026

VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy

Indeterminate GlobeNewswire

Oct. 7, 2026

Matchpoint Therapeutics Announces $150 Million Series B Financing to Advance Pipeline of First-In-Class Oral Small Molecules for Autoimmune and Inflammatory Diseases

Indeterminate GlobeNewswire

Oct. 7, 2026

Atavistik Bio to Present at the Cure HHT 16th International Scientific Conference

Indeterminate GlobeNewswire

Oct. 7, 2026

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease

Indeterminate GlobeNewswire

Oct. 7, 2026

BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds

Indeterminate GlobeNewswire

Oct. 7, 2026

Alpha Compute’s GAMEE Reports Q3 Record 94% YoY Growth, Reaches Monthly Profitability with over 118 million game-plays, Expands Into AI-Powered Consumer Applications

Indeterminate GlobeNewswire

Oct. 7, 2026

Eclipse Qrisp wins Quantum Effects Award 2026 for advancing quantum software development

Indeterminate GlobeNewswire

Oct. 7, 2026

Sixthfin Enterprise Financial Close Management Platform Brings a Single Review Standard to UK Groups Running Multiple ERP Systems

Indeterminate GlobeNewswire

Oct. 7, 2026

Cliq Digital AG beschließt Durchführung eines öffentlichen Teilrückerwerbsangebots für bis zu 10% des Grundkapitals der Gesellschaft

Indeterminate GlobeNewswire

Oct. 7, 2026

Cliq Digital AG decides to conduct a public partial share repurchase offer for up to 10% of the Company's share capital

Indeterminate GlobeNewswire

Oct. 7, 2026

MUVON Therapeutics Reports Positive 12-Month Phase 2 Follow-up Data Confirming Durable Efficacy of its First-in-Class Muscle Regeneration Therapy in Stress Urinary Incontinence

Indeterminate GlobeNewswire

Oct. 7, 2026

ITM and Lumara Bio to Announce New Data for ¹⁷⁷Lu-edotreotide (ITM-11) and Ga-DPI-4452 at EANM 2026

Indeterminate GlobeNewswire

Oct. 7, 2026

Securonix Named to 2026 Fortune Future 120 for Long-Term Growth Potential

Indeterminate GlobeNewswire

Oct. 7, 2026

BIO-Europe C-Suite Survey: Biopharma dealmaking set to accelerate, but investor caution still caps ambition

Indeterminate GlobeNewswire

Oct. 7, 2026

PulseSight presents PST-611 Phase I new early clinical efficacy data at EURETINA, offering a potential breakthrough approach to treat Dry AMD/Geographic Atrophy

Indeterminate GlobeNewswire

Oct. 7, 2026

Percona Announces Valkey-proxy, an Open Source Project to Ease Enterprise Migration to Valkey

Indeterminate GlobeNewswire

Oct. 7, 2026

Syncron Launches Service Contract Performance to Help OEMs Grow Profitable Service Revenue

Indeterminate GlobeNewswire

Oct. 7, 2026

Sereact, Zalando and CEVA Logistics start AI-powered, automated returns handling in Germany and Poland

Indeterminate GlobeNewswire

Oct. 7, 2026

Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day

Indeterminate GlobeNewswire